This vaccine did previously have emergency approval by the FDA for use but can now be marketed in the U.S. for use, the ...

The U.S. Food and Drug Administration approved Novavax's Covid-19 vaccine with age restrictions after a six-week delay.

The U.S. Food and Drug Administration approved Novavax's COVID-19 vaccine, but limited its use to older adults and people ...

The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with unusual ...

Some trials are focusing on drugs that target the immune system, which is affected by different pathways to long covid.

After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...

The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.

Researchers looked at biomarkers in study participants and found that those complaining of brain fog had higher levels of an ...

Populations in major American cities have bounced back from pandemic-induced drops, with New York, Houston and Los Angeles ...

With new testing requirements, it’s not even clear whether new Covid or flu shots can be made available this fall.

A new report says Health and Human Services Secretary Robert F. Kennedy Jr. will roll back current CDC guidance on COVID ...